Nell Beattie's most recent trade in VBI Vaccines Inc. was a trade of 52,500 Option (Right to Buy Common Shares) done . Disclosure was reported to the exchange on July 27, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
VBI Vaccines Inc. | Nell Beattie | Director, CFO, Head of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2023 | 52,500 | 52,500 | - | - | Option (Right to Buy Common Shares) | |
VBI Vaccines Inc. | Nell Beattie | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 75,000 | 75,000 | - | - | Option (Right to Buy Common Shares) | |
VBI Vaccines Inc. | Nell Beattie | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 400,000 | 400,000 | - | - | Option (Right to Buy Common Shares) | |
VBI Vaccines Inc. | Nell Beattie | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 03 Dec 2021 | 8,200 | 68,200 (0%) | 0% | 2.4 | 20,083 | Common Shares, no par value per share |
VBI Vaccines Inc. | Nell Beattie | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 500,000 | 500,000 | - | - | Option (Right to Buy Common Shares) | |
VBI Vaccines Inc. | Nell Beattie | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 170,100 | 170,100 | - | - | Option (Right to Buy Common Shares) |